These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35672205)

  • 21. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
    Motoyama R; Yamakawa K; Suzuki S; Kusunoki S; Tanaka M
    Rinsho Shinkeigaku; 2011 Oct; 51(10):761-4. PubMed ID: 22019868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L; Kaboré R; Mathis S; Lebeau P; Ghorab K; Caudie C; Vallat JM
    J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure.
    Puma A; Grecu N; Badea RȘ; Morisot A; Zugravu R; Ioncea MB; Cavalli M; Lăcătuș O; Ezaru A; Hacina C; Villa L; Raffaelli C; Azulay N; Sacconi S
    Sci Rep; 2024 Feb; 14(1):4643. PubMed ID: 38409319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
    Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
    Liu B; Hu J; Sun C; Qiao K; Xi J; Zheng Y; Sun J; Luo S; Zhao Y; Lu J; Lin J; Zhao C
    J Neurol; 2023 Sep; 270(9):4288-4295. PubMed ID: 37195346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
    Capasso M; Torrieri F; Di Muzio A; De Angelis MV; Lugaresi A; Uncini A
    Clin Neurophysiol; 2002 Mar; 113(3):346-53. PubMed ID: 11897535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Immune-Mediated Polyneuropathies.
    Cox SZ; Gwathmey KG
    Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In the borderland of multifocal motor neuropathy and chronic inflammatory demyelinating polyradiculopathy.
    Topakian R; Müller P; Ciovica-Oel IC; Trenkler J
    Neurol Sci; 2021 Mar; 42(3):1131-1134. PubMed ID: 33074453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia.
    Park SB; Li T; Kiernan MC; Garg N; Wilson I; White R; Boggild M; McNabb A; Lee-Archer M; Taylor BV
    Muscle Nerve; 2022 Nov; 66(5):576-582. PubMed ID: 36054471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
    Parisi M; Dogliotti I; Clerico M; Bertuzzo D; Benevolo G; Orsucci L; Schiavetti I; Cavallo R; Cavallo F; Ragaini S; Di Liberto A; Ferrante M; Bondielli G; Artusi CA; Drandi D; Lopiano L; Ferrero B; Ferrero S
    Eur J Neurol; 2022 Dec; 29(12):3611-3622. PubMed ID: 36083713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve Pathology Distinguishes Focal Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy From Multifocal Motor Neuropathy.
    Tracy JA; Taylor BV; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Dyck PJB
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):1-10. PubMed ID: 32833719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
    Iijima M
    Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Léger JM
    Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
    Kuwabara S
    Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.